Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T75440 | Target Info | |||
Target Name | Translocator protein (TSPO) | ||||
Synonyms |
Peripheral-type benzodiazepine receptor; Peripheral benzodiazepine receptor; PKBS; PBR; Mitochondrial benzodiazepine receptor; MBR; BZRP
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | TSPO | ||||
Biochemical Class | Cholesterol/porphyrin uptake translocator | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Matrix metalloproteinase-2 (MMP-2) | Successful Target | ||||
UniProt ID | MMP2_HUMAN | |||||
Gene Name | MMP2 | |||||
Synonyms |
TBE-1; Matrix metalloproteinase 2; CLG4A; 72 kDa type IV collagenase; 72 kDa gelatinase
Click to Show/Hide
|
|||||
Representative Drug(s) | TLN-4601 | Drug Info | IC50 = 0.46 ug.mL-1 | [1] | ||
Co-Target Name | GABA(A) receptor alpha-1 (GABRA1) | Successful Target | ||||
UniProt ID | GBRA1_HUMAN | |||||
Gene Name | GABRA1 | |||||
Synonyms |
Gamma-aminobutyric acid receptor subunit alpha-1; GABA(A) receptor subunit alpha-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 3.3 nM | Click to Show More | [2] | |
2 | Diazepam | Drug Info | Ki = 16 nM | [4] | ||
3 | Alprazolam | Drug Info | EC50 = 37 nM | [3] | ||
4 | Eszopiclone | Drug Info | Ki = 50.1 nM | [2] | ||
Co-Target Name | GABA(A) receptor alpha-5 (GABRA5) | Successful Target | ||||
UniProt ID | GBRA5_HUMAN | |||||
Gene Name | GABRA5 | |||||
Synonyms |
GABRA5; GABAA alpha 5; GABA-A alpha-5
Click to Show/Hide
|
|||||
Representative Drug(s) | Alprazolam | Drug Info | EC50 = 10 nM | Click to Show More | [3] | |
2 | Diazepam | Drug Info | Ki = 15 nM | [4] | ||
Co-Target Name | GABA(A) receptor alpha-2 (GABRA2) | Successful Target | ||||
UniProt ID | GBRA2_HUMAN | |||||
Gene Name | GABRA2 | |||||
Synonyms |
GABRA2; GABA-A receptor alpha 2; GABA(A)Gamma-aminobutyric-acid receptor alpha-2 subunit precursor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Alprazolam | Drug Info | EC50 = 12 nM | Click to Show More | [3] | |
2 | Diazepam | Drug Info | Ki = 17 nM | [4] | ||
Co-Target Name | GABA(A) receptor alpha-3 (GABRA3) | Successful Target | ||||
UniProt ID | GBRA3_HUMAN | |||||
Gene Name | GABRA3 | |||||
Synonyms |
Gamma-aminobutyric acid receptor subunit alpha-3; GABA-A receptor alpha 3; GABA(A)Gamma-aminobutyric-acid receptor alpha-3 subunit precursor receptor; GABA(A) receptor subunit alpha-3
Click to Show/Hide
|
|||||
Representative Drug(s) | Diazepam | Drug Info | Ki = 17 nM | Click to Show More | [4] | |
2 | Alprazolam | Drug Info | EC50 = 69 nM | [3] | ||
Co-Target Name | Matrix metalloproteinase-9 (MMP-9) | Clinical trial Target | ||||
UniProt ID | MMP9_HUMAN | |||||
Gene Name | MMP9 | |||||
Synonyms |
Matrix metalloproteinase 9; GELB; CLG4B; 92 kDa type IV collagenase; 92 kDa gelatinase
Click to Show/Hide
|
|||||
Representative Drug(s) | TLN-4601 | Drug Info | IC50 = 0.6 ug.mL-1 | [1] | ||
Co-Target Name | GABA A receptor alpha-2/beta-3/gamma-2 (GABRA2/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA2_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA2-GABRB3-GABRG2 | |||||
Representative Drug(s) | Drug Info | Ki = 0.59 nM | Click to Show More | [5] | ||
2 | Flumazenil | Drug Info | Ki = 0.9 nM | [5] | ||
3 | Drug Info | Ki = 1.1 nM | [8] | |||
4 | Diazepam | Drug Info | Ki = 6.6 nM | [8] | ||
5 | Chlordiazepoxide | Drug Info | Ki = 392 nM | [17] | ||
Co-Target Name | GABA A receptor alpha-5/beta-3/gamma-2 (GABRA5/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA5_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA5-GABRB3-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 0.6 nM | Click to Show More | [6] | |
2 | Drug Info | Ki = 1.54 nM | [5] | |||
3 | Drug Info | Ki = 2.1 nM | [5] | |||
4 | Diazepam | Drug Info | Ki = 11 nM | [13] | ||
5 | Chlordiazepoxide | Drug Info | Ki = 320 nM | [16] | ||
Co-Target Name | GABA A receptor alpha-1/beta-2/gamma-2 (GABRA1/GABRB2/GABRG2) | Co-Target | ||||
UniProt ID | GBRA1_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA1-GABRB2-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 0.8 nM | Click to Show More | [6] | |
2 | Drug Info | Ki = 0.8 nM | [5] | |||
3 | Flumazenil | Drug Info | Ki = 0.8 nM | [6] | ||
4 | Drug Info | Ki = 0.8 nM | [5] | |||
5 | Drug Info | EC50 = 1.4 nM | [9] | |||
6 | Drug Info | EC50 = 1.4 nM | [9] | |||
7 | Drug Info | Ki = 2.2 nM | [10] | |||
8 | Drug Info | Ki = 2.2 nM | [10] | |||
9 | Diazepam | Drug Info | Ki = 12 nM | [8] | ||
10 | Diazepam | Drug Info | Ki = 12 nM | [8] | ||
11 | Diazepam | Drug Info | Ki = 13 nM | [15] | ||
12 | Diazepam | Drug Info | Ki = 13 nM | [15] | ||
13 | Chlordiazepoxide | Drug Info | Ki = 560 nM | [16] | ||
14 | Chlordiazepoxide | Drug Info | Ki = 560 nM | [16] | ||
Co-Target Name | GABA-A receptor anion channel | Co-Target | ||||
UniProt ID | GBRE_HUMAN; GBRP_HUMAN | |||||
Gene Name | GABRE; GABRP | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 0.9 nM | Click to Show More | [7] | |
2 | Diazepam | Drug Info | IC50 = 8.1 nM | [11] | ||
Co-Target Name | GABA A receptor alpha-3/beta-3/gamma-2 (GABRA3/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA3_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA3-GABRB3-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 1.05 nM | Click to Show More | [6] | |
2 | Drug Info | Ki = 1.43 nM | [5] | |||
3 | Drug Info | Ki = 4.5 nM | [5] | |||
4 | Diazepam | Drug Info | Ki = 15 nM | [5] | ||
5 | Chlordiazepoxide | Drug Info | Ki = 275 nM | [16] | ||
Co-Target Name | GABA receptor alpha-4 (GABRA4) | Co-Target | ||||
UniProt ID | GBRA4_HUMAN | |||||
Gene Name | GABRA4 | |||||
Synonyms |
Gamma-aminobutyric acid receptor subunit alpha-4; GABA(A) receptor subunit alpha-4
Click to Show/Hide
|
|||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 2 nM | Click to Show More | [2] | |
2 | Eszopiclone | Drug Info | Ki = 102 nM | [2] | ||
Co-Target Name | GABA A receptor alpha-2/beta-2/gamma-2 (GABRA2/GABRB2/GABRG2) | Co-Target | ||||
UniProt ID | GBRA2_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA2-GABRB2-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 5.7 nM | Click to Show More | [2] | |
2 | Eszopiclone | Drug Info | Ki = 114 nM | [2] | ||
Co-Target Name | GABA A receptor alpha-3/beta-2/gamma-2 (GABRA3/GABRB2/GABRG2) | Co-Target | ||||
UniProt ID | GBRA3_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA3-GABRB2-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 8.1 nM | Click to Show More | [2] | |
2 | Diazepam | Drug Info | Ki = 10 nM | [12] | ||
3 | Eszopiclone | Drug Info | Ki = 162 nM | [2] | ||
Co-Target Name | GABA A receptor alpha-1/beta-1/gamma-2 (GABRA1/GABRB1/GABRG2) | Co-Target | ||||
UniProt ID | GBRA1_HUMAN-GBRB1_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA1-GABRB1-GABRG2 | |||||
Representative Drug(s) | Diazepam | Drug Info | Ki = 12 nM | [14] | ||
Co-Target Name | GABA A receptor alpha-6/beta-3/gamma-2 (GABRA6/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA6_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA6-GABRB3-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 148 nM | [6] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Anti-invasive and anti-angiogenic activities of naturally occurring dibenzodiazepine BU-4664L and its derivatives. Bioorg Med Chem Lett. 2010 Feb 1;20(3):963-5. | ||||
REF 2 | Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different. J Med Chem. 2008 Nov 27;51(22):7243-52. | ||||
REF 3 | Synthesis and biological evaluation of 7,8,9,10-tetrahydroimidazo[1,2-c]pyrido[3,4-e]pyrimdin-5(6H)-ones as functionally selective ligands of the benzodiazepine receptor site on the GABA(A) receptor. J Med Chem. 2002 Nov 7;45(23):5043-51. | ||||
REF 4 | Subtype Selective gamma-Aminobutyric Acid Type A Receptor (GABA A R) Modulators Acting at the Benzodiazepine Binding Site: An Update. J Med Chem. 2020 Apr 9;63(7):3425-3446. | ||||
REF 5 | Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach. J Med Chem. 2000 Jan 13;43(1):71-95. | ||||
REF 6 | Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines a... J Med Chem. 1998 Oct 8;41(21):4130-42. | ||||
REF 7 | High affinity central benzodiazepine receptor ligands: synthesis and biological evaluation of a series of phenyltriazolobenzotriazindione derivatives. J Med Chem. 2005 Apr 21;48(8):2936-43. | ||||
REF 8 | N-(indol-3-ylglyoxylyl)piperidines: high affinity agonists of human GABA-A receptors containing the alpha1 subunit. Bioorg Med Chem Lett. 2000 Jun 19;10(12):1381-4. | ||||
REF 9 | Protein kinase C epsilon regulates gamma-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of gamma2... J Biol Chem. 2007 Nov 9;282(45):33052-63. | ||||
REF 10 | Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) a... J Med Chem. 1998 Jul 2;41(14):2537-52. | ||||
REF 11 | Quinazolines and 1,4-benzodiazepines. 90. Structure-activity relationship between substituted 2-amino-N-(2-benzoyl-4-chlorophenyl)acetamides and 1,4-benzodiazepinones. J Med Chem. 1982 Sep;25(9):1050-5. | ||||
REF 12 | High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the gamma-aminobutyric acid A/benzodiazepine receptor complex. J Med Chem. 1996 Jan 5;39(1):158-75. | ||||
REF 13 | Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit. J Med Chem. 2005 Mar 10;48(5):1367-83. | ||||
REF 14 | 4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore mod... J Med Chem. 2006 Apr 20;49(8):2526-33. | ||||
REF 15 | Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxiety. J Med Chem. 2006 Feb 23;49(4):1235-8. | ||||
REF 16 | 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels. J Med Chem. 2002 Apr 25;45(9):1887-900. | ||||
REF 17 | 3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of alpha5-containing GABAA receptors. Bioorg Med Chem Lett. 2004 Jun 7;14(11):2871-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.